Navigation Links
Microbia Announces Name Change to Ironwood Pharmaceuticals
Date:4/7/2008

CAMBRIDGE, Mass., April 7, 2008 /PRNewswire/ -- Microbia, Inc. today announced that it has changed its name to Ironwood Pharmaceuticals, Inc. The ironwood is a long-lived tree that thrives in the harshest desert environment, with some trees surviving as long as 1,500 years. Known as a "nurse tree," it provides a shaded microclimate with lower temperatures, higher water availability, and more organic matter for birds, reptiles, insects, animals, and plants. In addition, the name Ironwood encompasses the inorganic and organic -- the properties of essential elements and the characteristics of life.

"As Microbia has developed and progressed, we have outgrown the usefulness of the name Microbia," said Peter Hecht, CEO. "With that in mind, we sought a name for the company that reflects our approach to creating important human medicines. Because our research efforts are not limited to a single therapeutic area, we require a name that will accommodate a broad range of discoveries and products. We chose a name that not only suits us today, but also can endure for 100 years."

Additional information can be found at http://www.ironwoodpharma.com.

About Ironwood Pharmaceuticals (formerly Microbia)

Ironwood Pharmaceuticals (http://www.ironwoodpharma.com) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. The Company is advancing several clinical candidates -- linaclotide for the treatment of irritable bowel syndrome with constipation, chronic constipation and other functional gastrointestinal disorders; and novel, next-generation cholesterol absorption inhibitors for the treatment of hypercholesterolemia. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia Precision Engineering, Inc., a majority-owned subsidiary of Ironwood Pha
'/>"/>

SOURCE Microbia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. New Microbial Genome-to-Array Service
2. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
3. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
4. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
5. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
6. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. Medicsight Announces New Marketing Partnership with INFINITT
9. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
10. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
11. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... Kennedy Joins with State Biotech Leaders to ... Research and Development while Boosting Rhode Island,s ... ,, PROVIDENCE, R.I., Dec. 14 ... in research, medicine and biotechnology gathered today ... discuss the importance of medical innovation in ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... Inc., a,biopharmaceutical company focused on the discovery ... treatment of metabolic diseases,announced today that Donald ... chief,financial officer. Mr. Hill brings extensive financial ... in business,development, treasury management and controllership of ...
... basis of blood-based ColonSentry(TM) test -, TORONTO, ... company focused on developing blood-based biomarker tests for ... today reported,positive performance results from a large validation ... of a patient,s current risk for,colorectal cancer. This ...
... SeqWright Inc., a leading Genomics,CRO, has added ... of its next,generation offerings and to provide genomic ... FLX(TM) system will complement,SeqWright,s current ABI SOLiD(TM) platform ... array of next generation services, including de novo,sequencing ...
Other Biology Technology:Metabolex Appoints Donald Hill as Chief Financial Officer 2GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR 2GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR 3SeqWright Expands Next Generation Lineup with the Addition of 454's GS FLX(TM) System 2
(Date:12/14/2009)... of Alberta researchers are part of an international team ... fossilized bones, to revise the history of North America,s ... U of A Earth and Atmospheric Sciences professor Duane ... based on radiocarbon dating of bones and teeth. That ... mammals in North America (the ,megafauna,) disappeared about 13,000 ...
(Date:12/14/2009)... at Rice University and Baylor College of Medicine (BCM) ... in real time with MRI as it homes in ... and kills them with heat. The all-in-one particle is ... called "theranostics" that develops technologies physicians can use to ... The research is available online in the journal ...
(Date:12/14/2009)... novel antifreeze molecule in a freeze-tolerant Alaska beetle able ... all previously described biological antifreezes that contain protein, this ... It is composed of a sugar and a fatty ... cells of organisms. , "The most exciting part ... whole new kind of antifreeze that may work in ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Scientists isolate new antifreeze molecule in Alaska beetle 2MS study offers theory for why repair of brains wiring fails 9082 1MS study offers theory for why repair of brains wiring fails 9082 2MS study offers theory for why repair of brains wiring fails 9082 3MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 1MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 2Emerging Techniques Put a New Twist on Ankle Repair 50502 1Emerging Techniques Put a New Twist on Ankle Repair 50502 2Emerging Techniques Put a New Twist on Ankle Repair 50502 3
... Dr Takaaki Sokabe, National Institute for Physiological Sciences (NIPS), Japan, ... noxious heat. The research group reports their finding in ... It has been unknown how flies detect a noxious heat ... "Painless" protein, which had been known to be important for ...
... Journal ( http://www.fasebj.org ) suggests that pregnant women ... from the University of Cincinnati and the Medical College ... fat diets were more likely to have oversized offspring ... causes the placenta to go into "overdrive" by providing ...
... that,s past its best - and Icelandic scientists can now ... faster than ever before. , The research in the Royal ... a new method to detect bacteria that break down dead ... It opens the door to a standard of quality control ...
Other Biology News:Scientists discover why a mother's high-fat diet contributes to obesity in her children 2
GLP-compliant, CLIA-certified DNA sequencing service. ASQ and SQA certified quality assurance staff. Auditors welcome....
A component of the Acridinium protein labeling kit....
...
...
Biology Products: